Recent studies have pointed out that GLP-1 can increase the expression of ABCA1 and ABCG1 in ApoE -/- mice, thereby reducing the area of aortic plaque in HF raised ApoE -/- mice and realizing the reverse transport of aortic plaque
(March 2018)
Consider asking about other GLP-1s, such as Foundayo (orforglipron) and Saxenda (liraglutide)
This suggests that some therapeutic benefits of canagliflozin could result from the activation of AMPK, rather than inhibition of SGLT2 ( DPP-4 inhibitors These compounds, by preventing deactivation by dipeptidyl peptidase-4 (DPP4) inhibitors, improve the concentration of endogenous incretins (Vangoitsenhoven et al., 2012)
The peptides relatively short half-life in the bloodstream does not affect its stability in storage, but certain conditions can degrade it quickly
Heres what to watch out for: Using CJC1295 With DAC When Its Not Needed The DAC (Drug Affinity Complex) version of CJC1295 extends its half-life, but that doesnt always mean better results